IN BRIEF: Tissue Regenix granted European patent for dCELL
Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Says European Patent Office grants European patent (EP4114476) for its decellularisation technology, dCELL. The patent relates to the method for producing decellularisation tissue scaffold which is a foundation for Tissue Regenix's platform and plays a pivotal role in the development of its product range. This patent adds to those the company already has granted in the US and UK for dCELL. Read More